Download full-text PDF |
Source |
---|
Surg Endosc
May 2023
Division of Visceral Surgery, Department of General Surgery, Medical University of Vienna, Waehringer Guertel 18-20, Vienna, 1090, Austria.
Background: One-Anastomosis Gastric Bypass (OAGB) is the third most common bariatric operation for patients with obesity worldwide. One concern about OAGB is the presence of acid and non-acid reflux in a mid- and long-term follow-up. The aim of this study was to objectively evaluate reflux and esophagus motility by comparing preoperative and postoperative mid-term outcomes.
View Article and Find Full Text PDFKhirurgiia (Mosk)
March 2022
Tomsk Regional Clinical Hospital, Tomsk, Russia.
Objective: To describe 10-year experience of treating the cicatricial tracheal stenosis (CTS) in a regional multi-field hospital.
Material And Methods: There were 120 CTS patients aged 13-75 years. In 8 (6.
Georgian Med News
September 2020
1Sechenov First Moscow State Medical University, Moscow, Russian Federation.
We studied the immediate and long-term results of various methods of gastric resection in 35 patients operated at the S.S. Yudin State Medical Center in Moscow from 2000 to 2019.
View Article and Find Full Text PDFAnn Med Surg (Lond)
March 2016
Emergency General Surgery and Major Trauma Centre, General Surgery Department, University of Liverpool, Aintree University Hospital NHS Foundation Trust, Lower Lane, Liverpool, L9 7AL, United Kingdom.
Background: The study was aimed to delineate the postoperative morbidity, mortality and long-term follow-up results after R0 subtotal gastrectomy with D2 lymphadenectomy for invasive non-disseminated adenocarcinoma of the distal gastric portion.
Methods: Between January 2005 and December 2007, 228 patients with median age at hospitalisation 66.6 ± 11.
Am J Transplant
May 2011
Department of General, Visceral and Transplantation Surgery, Charité-Universitaetsmedizin Berlin, Campus Virchow Klinikum, Berlin, Germany.
We reported the successful administration of infliximab for late-onset OKT3-resistant rejection in two patients, who presented persistent ulcerative inflammation of the ileal graft after intestinal transplantation (ITX). Based on this experience, the present study demonstrated our long-term experience with infliximab for different types of rejection-related and inflammatory allograft alterations. Infliximab administration (5 mg/kg body weight (BW)) was initiated at a mean of 18.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!